Даже благодаря одной прививке коронавирус проходит легче: что выяснили ученые from-ua.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from from-ua.com Daily Mail and Mail on Sunday newspapers.
Federation of European Microbiological Societies and American Society of Microbiology announce World Microbe Forum
Introducing World Microbe Forum, a Digital Meeting of the Microbial Sciences.
Despite physical distancing resulting from the pandemic, microbial scientists will convene digitally for a unique gathering covering cutting-edge, interdisciplinary microbial sciences research.
Recognizing that microbial sciences, just like microbes, know no borders, the Federation of European Microbiological Societies (FEMS) and the American Society of Microbiology (ASM) are excited to announce the World Microbe Forum –
a collaboration bringing two of the biggest events in the microbial sciences, ASM Microbe and FEMS2021, together. The forum will take place from 20-24 June 2021.
Research teams in Montreal, Toronto looking at how COVID-19 impacts immunity
Last Updated Dec 17, 2020 at 1:23 pm MDT
FILE Specimens to be tested for COVID-19 are seen at a lab, in Surrey, B.C., on Thursday, March 26, 2020. THE CANADIAN PRESS/Darryl Dyck
MONTREAL – Research from two university teams is shedding a little bit of light on why COVID-19 patients have more severe side effects than those with the regular seasonal flu.
The teams, from the Université de Montréal and the University of Toronto are backed by Canada’s COVID-19 Immunity Task Force (CITF). The Toronto team recently had its findings shared in the Journal of Immunology.
Quick collaboration sent-trib.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sent-trib.com Daily Mail and Mail on Sunday newspapers.
Dec 11, 2020
Malin Dunfors, Market One Media Algernon Pharmaceuticals has been hard at work repurposing Ifenprodil for those affected by idiopathic pulmonary fibrosis, chronic cough, as well as COVID-19. , Market One Media
New England Journal of Medicine reports that four repurposed antiviral drugs tested in 11,330 patients hospitalized with COVID-19 showed little to no effect
Decemberâs release of interim data from the companyâs Ifenprodil COVID-19 multinational trial marks important milestone
The IPF (Idiopathic Pulmonary Fibrosis) market is expected to grow to USD$3.6 billion by 2029
In mid-January, scientists published the genetic sequence of the coronavirus, thought to be behind the outbreak of a new form of pneumonia. Not long after, the hunt for a potential coronavirus vaccine began.